Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway

References

• Zhang X, Zhou Y, Gu YE. Tanshinone IIA induces apoptosis of ovarian cancer cells in vitro and in vivo through attenuation of PI3K/AKT/JNK signaling pathways. Oncol Lett. 2019;17(2):1896–1902.
   PubMed Web of Science ®Google Scholar
• Li K, Liu W, Zhao Q, et al. Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer. Phytother Res. 2019;33(6):1658–1669.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Geng Y, He J, et al. Tanshinone IIA induces apoptosis and autophagy in acute monocytic leukemia via downregulation of PI3K/Akt pathway. Am J Transl Res. 2019;11(5):2995–3006.
   PubMed Web of Science ®Google Scholar
• Ma L, Jiang H, Xu X, et al. Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway. Aging (Albany NY)). 2019;11(21):9719–9737.
   PubMedGoogle Scholar
• Zhang Y, Ge T, Xiang P, et al. Tanshinone IIA reverses oxaliplatin resistance in human colorectal cancer via inhibition of ERK/Akt signaling pathway. Onco Targets Ther. 2019;12:9725–9734.
   PubMed Web of Science ®Google Scholar
• Luo C, Xu X, Wei X, et al. Natural medicines for the treatment of fatigue: bioactive components, pharmacology, and mechanisms. Pharmacol Res. 2019;148:104409.
   PubMed Web of Science ®Google Scholar
• Hao L, Sun Q, Zhong W, et al. Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: a molecular mechanism of protection against alcoholic liver disease. Redox Biol. 2018;14:626–636.
   PubMed Web of Science ®Google Scholar
• McKiernan AP. Inhaler spray investigation using high-speed phase-contrast X-ray and Schlieren imaging. Pharm Res. 2019;36(8):120.
   PubMed Web of Science ®Google Scholar
• Fukushima K, Otagaki S, Takahashi K, et al. Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells. J Recept Signal Transduct Res. 2018;38(4):367–371.
   PubMed Web of Science ®Google Scholar
• Kamel WA, Sugihara E, Nobusue H, et al. Simvastatin-induced apoptosis in osteosarcoma cells: a key role of RhoA-AMPK/p38 MAPK signaling in antitumor activity. Mol Cancer Ther. 2017;16(1):182–192.
   PubMed Web of Science ®Google Scholar
• Ying H, Wang Z, Zhang Y, et al. Capsaicin induces apoptosis in human osteosarcoma cells through AMPK-dependent and AMPK-independent signaling pathways. Mol Cell Biochem. 2013;384(1-2):229–237.
   PubMed Web of Science ®Google Scholar
• Nisthul AA, Retnakumari AP, A S, et al. In silico screening for identification of fatty acid synthase inhibitors and evaluation of their antiproliferative activity using human cancer cell lines. J Recept Signal Transduct Res. 2018;38(4):335–341.
   PubMed Web of Science ®Google Scholar
• Stauffer S, Zeng Y, Santos M, et al. Cyclin-dependent kinase 1-mediated AMPK phosphorylation regulates chromosome alignment and mitotic progression. J Cell Sci. 2019;132(20):jcs236000.
   PubMed Web of Science ®Google Scholar
• Wu D, Cheng Y, Wang X, CSGT group. Definition of clinical gene tests. Cell Biol Toxicol. 2019;35(2):83–87.
   PubMed Web of Science ®Google Scholar
• Montllor-Albalate C, Colin AE, Chandrasekharan B, et al. Extra-mitochondrial Cu/Zn superoxide dismutase (Sod1) is dispensable for protection against oxidative stress but mediates peroxide signaling in Saccharomyces cerevisiae. Redox Biol. 2019;21:101064.
   PubMed Web of Science ®Google Scholar
• Mekala NK, Kurdys J, Depuydt MM, et al. Apoptosis inducing factor deficiency causes retinal photoreceptor degeneration. The protective role of the redox compound methylene blue. Redox Biol. 2019;20:107–117.
   PubMed Web of Science ®Google Scholar
• Mehta A, Dalle Vedove E, Isert L, et al. Targeting KRAS mutant lung cancer cells with siRNA-loaded bovine serum albumin nanoparticles. Pharm Res. 2019;36(9):133.
   PubMed Web of Science ®Google Scholar
• Zhu L, Wang J, Kong W, et al. LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling. Acta Pharm Sin B. 2019;9(2):324–334.
   PubMed Web of Science ®Google Scholar
• Liu Q, Wang K. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. Cell Biol Int. 2019;43(11):1245–1256.
   PubMed Web of Science ®Google Scholar
• Avalle L, Camporeale A, Morciano G, et al. STAT3 localizes to the ER, acting as a gatekeeper for ER-mitochondrion Ca2+ fluxes and apoptotic responses. Cell Death Differ. 2019;26(5):932–942.
   PubMed Web of Science ®Google Scholar
• Shih YM, Cooke MS, Pan CH, et al. Clinical relevance of guanine-derived urinary biomarkers of oxidative stress, determined by LC-MS/MS. Redox Biol. 2019;20:556–565.
   PubMed Web of Science ®Google Scholar
• Kong S, Zhang Y. Deciphering Hi-C: from 3D genome to function. Cell Biol Toxicol. 2019;35(1):15–32.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang P, Zhang L, et al. Superhero Rictor promotes cellular differentiation of mouse embryonic stem cells. Cell Death Differ. 2019;26(5):958–968.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Zhou X, Curbo S, et al. Metformin downregulates the mitochondrial carrier SLC25A10 in a glucose dependent manner. Biochem Pharmacol. 2018;156:444–450.
   PubMed Web of Science ®Google Scholar
• Ekins S, Gerlach J, Zorn KM, et al. Repurposing approved drugs as inhibitors of Kv7.1 and Nav1.8 to treat Pitt Hopkins syndrome. Pharm Res. 2019;36(9):137.
   PubMed Web of Science ®Google Scholar
• Zhou X, Wu Y, Ye L, et al. Aspirin alleviates endothelial gap junction dysfunction through inhibition of NLRP3 inflammasome activation in LPS-induced vascular injury. Acta Pharm Sin B. 2019;9(4):711–723.
   PubMed Web of Science ®Google Scholar
• Teschler M, Mooren FC. (Whole-Body) Electromyostimulation, muscle damage, and immune system: a mini review. Front Physiol. 2019;10:1461.
   PubMed Web of Science ®Google Scholar
• Zhang S, Huang F, Tian W, et al. Andrographolide promotes pancreatic duct cells differentiation into insulin-producing cells by targeting PDX-1. Biochem Pharmacol. 2020;174:113785.
   PubMed Web of Science ®Google Scholar
• Xie F, De Clercq K, Vervaet C, et al. Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice. Pharm Res. 2019;36(9):127.
   PubMed Web of Science ®Google Scholar
• Nybo T, Dieterich S, Gamon LF, et al. Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase. Redox Biol. 2019;20:496–513.
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Atkin SL, Simental-Mendia LE, et al. Anti-inflammatory effects of resolvins in diabetic nephropathy: mechanistic pathways. J Cell Physiol. 2019;234(9):14873–14882.
   Web of Science ®Google Scholar
• Shiri F, Pirhadi S, Rahmani A. Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening. J Recept Signal Transduct Res. 2018;38(1):37–47.
   PubMed Web of Science ®Google Scholar
• Gutierrez DA, DeJesus RE, Contreras L, et al. A new pyridazinone exhibits potent cytotoxicity on human cancer cells via apoptosis and poly-ubiquitinated protein accumulation. Cell Biol Toxicol. 2019;35(6):503–519.
   PubMed Web of Science ®Google Scholar
• Xue D, Chen Y, Li J, et al. A novel noncoding RNA dsr11 involved in heat stress tolerance in Deinococcus radiodurans. Biomolecules. 2019;10(1):22.
   Web of Science ®Google Scholar
• Zhong L, Xu L, Liu Y, et al. Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy. Acta Pharm Sin B. 2019;9(2):397–409.
   PubMed Web of Science ®Google Scholar
• Roy A, Sarker S, Upadhyay P, et al. Methylglyoxal at metronomic doses sensitizes breast cancer cells to doxorubicin and cisplatin causing synergistic induction of programmed cell death and inhibition of stemness. Biochem Pharmacol. 2018;156:322–339.
   PubMed Web of Science ®Google Scholar
• Ham SW, Jeon HY, Jin X, et al. TP53 gain-of-function mutation promotes inflammation in glioblastoma. Cell Death Differ. 2019;26(3):409–425.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ma R, Cheng S, et al. Marrubenol inhibits osteosarcoma cancer cell growth by inducing autophagic cell death and inhibiting cancer cell migration and invasion. J Buon. 2018;23(3):729–734.
   PubMed Web of Science ®Google Scholar
• Morton AB, Smuder AJ, Wiggs MP, et al. Increased SOD2 in the diaphragm contributes to exercise-induced protection against ventilator-induced diaphragm dysfunction. Redox Biol. 2019;20:402–413.
   PubMed Web of Science ®Google Scholar
• Cao C, Yu H, Wu F, et al. Antibiotic anisomycin induces cell cycle arrest and apoptosis through inhibiting mitochondrial biogenesis in osteosarcoma. J Bioenerg Biomembr. 2017;49(6):437–443.
   PubMed Web of Science ®Google Scholar
• Tang Y, Xie M, Jiang N, et al. Icarisid II inhibits the proliferation of human osteosarcoma cells by inducing apoptosis and cell cycle arrest. Tumour Biol. 2017;39(6):1010428317705745.
   Google Scholar
• Zhao W, Zhou SF, Zhang ZP, et al. Gambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrest. Oncol Rep. 2011;25(5):1289–1295.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhu W, Kong X, et al. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer. Oncol Rep. 2019;42(5):1893–1903.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo S, Fang J, et al. Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer. Exp Ther Med. 2018;16(4):2931–2937.
   PubMed Web of Science ®Google Scholar
• Liao XZ, Gao Y, Huang S, et al. Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway. Phytother Res. 2019;33(9):2298–2309.
   PubMed Web of Science ®Google Scholar
• Jieensinue S, Zhu H, Li G, et al. Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways. BMC Cell Biol. 2018;19(1):21.
   PubMedGoogle Scholar
• Garcia D, Shaw RJ. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell. 2017;66(6):789–800.
   PubMed Web of Science ®Google Scholar
• Battistelli C, Sabarese G, Santangelo L, et al. The lncRNA HOTAIR transcription is controlled by HNF4α-induced chromatin topology modulation. Cell Death Differ. 2019;26(5):890–901.
   PubMed Web of Science ®Google Scholar
• Ha J, Guan KL, Kim J. AMPK and autophagy in glucose/glycogen metabolism. Mol Aspects Med. 2015;46:46–62.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hu X, Liu Y, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16(1):79.
   PubMedGoogle Scholar
• Denton D, Kumar S. Autophagy-dependent cell death. Cell Death Differ. 2019;26(4):605–616.
   PubMed Web of Science ®Google Scholar
• Sajadimajd S, Khazaei M. Oxidative stress and cancer: the role of Nrf2. Curr Cancer Drug Targets. 2018;18(6):538–557.
   PubMed Web of Science ®Google Scholar
• Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer. 2012;12(8):564–571.
   PubMed Web of Science ®Google Scholar
• Ge W, Zhao K, Wang X, et al. iASPP is an antioxidative factor and drives cancer growth and drug resistance by competing with Nrf2 for Keap1 binding. Cancer Cell. 2017;32(5):561–573 e6.
   PubMed Web of Science ®Google Scholar
• Pompili S, Sferra R, Gaudio E, et al. Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease?. Int J Mol Sci. 2019;20(16):4061.
   PubMed Web of Science ®Google Scholar
• Lee SB, Sellers BN, DeNicola GM. The regulation of NRF2 by nutrient-responsive signaling and its role in anabolic cancer metabolism. Antioxid Redox Signal. 2018;29(17):1774–1791.
   PubMed Web of Science ®Google Scholar
• Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26(1):99–114.
   PubMed Web of Science ®Google Scholar
• Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.
   PubMed Web of Science ®Google Scholar
• Mitsuishi Y, Taguchi K, Kawatani Y, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012;22(1):66–79.
   PubMed Web of Science ®Google Scholar
• Denton D, Xu T, Dayan S, et al. Dpp regulates autophagy-dependent midgut removal and signals to block ecdysone production. Cell Death Differ. 2019;26(4):763–778.
   PubMed Web of Science ®Google Scholar